Placebo for Guselkumab, Guselkumab - solution for injection in pre-filled syringe - 100 mg/mL, Guselkumab
CNTO1959CRD3004
Phase 3 small_molecule active
Quick answer
Placebo for Guselkumab, Guselkumab - solution for injection in pre-filled syringe - 100 mg/mL, Guselkumab for Moderately to Severely Active Crohn's Disease is a Phase 3 program (small_molecule) at Janssen-Cilag International N.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Janssen-Cilag International N.V.
- Indication
- Moderately to Severely Active Crohn's Disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active